Precipio Competitors and Similar CompaniesClear all

Precipio's competitors and similar companies include MDxHealth.
Precipio
Precipio
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
MDxHealth
MDxHealth
MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.
Founding Date
Founding Date
1997
Founding Date
2003
Type
Type
Public
Type
Public
Tags
Locations
Locations
Omaha, US HQ
Glasgow, GB
New Haven, US
Omaha, US
Locations
Herstal, BE HQ
Nijmegen, NL
Irvine, US
Plano, US
Employees
Employees
4235% increase
Employees
252
Valuation ($)
Valuation ($)
9.3 m
Valuation ($)
93.5 m

Financial

Revenue (est.)
Revenue (est.)
$24m (FY, 2025)
Revenue (est.)
$107.9m (FY, 2025)
Cost of goods
Cost of goods
$13.3m (FY, 2025)
Cost of goods
$36.1m (FY, 2025)
Gross profit
Gross profit
$10.7m (FY, 2025)
Gross profit
$71.8m (FY, 2025)
Net income
Net income
($363k) (FY, 2025)
Net income
($33.5m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 1.5m
Total funding raised
$ 1.1m
For sources of this data, please see the company profile

View Company Profiles

MDxHealth
HQ
Herstal, BE
Employees
252

MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.

View company